Showing results (411-420 of 646) with videos related to
Sort By:
Pageof 65
Annals of Surgery|July 1, 1989
Primary adrenal causes of Cushing's syndrome. Diagnosis and surgical managementR R Perry, L K Nieman, G B Cutler, et al.The Journal of Clinical Endocrinology and Metabolism|November 1, 1982
Metabolic clearance rate and plasma half-life of radioiodinated corticotropin releasing factor in a primateH M Schulte, G P Chrousos, P W Gold, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiencyM C Gelato, S Malozowski, M Caruso-Nicoletti, et al.Pediatric Research|September 1, 1986
Ovarian function in girls with McCune-Albright syndromeC M Foster, P Feuillan, V Padmanabhan, et al.Radiology|May 1, 1987
Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imagingA J Dwyer, J A Frank, J L Doppman, et al.The New England Journal of Medicine|October 6, 1991
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndromeE H Oldfield, J L Doppman, L K Nieman, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1984
Dissociation of cortisol and adrenal androgen secretion in the hypophysectomized, adrenocorticotropin-replaced chimpanzeeB D Albertson, W C Hobson, B S Burnett, et al.Lipids|June 13, 1998
A 13C nuclear magnetic resonance study of free fatty acid incorporation in acylated lipids in differentiating preadipocytesW Guo, J L Kirkland, B Corkey, et al.Pharmacology & Therapeutics|May 24, 2006
Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF)R Vlahos, S Bozinovski, J A Hamilton, et al.Journal of Leukocyte Biology|June 1, 1993
Effects of macrophage-colony stimulating factor on human monocytes: induction of expression of urokinase-type plasminogen activator, but not of secreted prostaglandin E2, interleukin-6, interleukin-1, or tumor necrosis factor-alphaJ A Hamilton, G A Whitty, H Stanton, et al.Pageof 65